For retail sale medicaments with penicillins or streptomycins market in Germany

Earlier Report Observations

The market for retail-packed penicillins and streptomycins in Germany showed considerable volatility between 2018 and 2024. After starting at 209.2 million US dollars in 2018, the market volume fell sharply to 160.6 million in 2019. This decline occurred alongside the launch of the new antibiotic temocillin, a penicillin derivative effective against some resistant strains, which expanded treatment options but did not reverse the overall contraction. A recovery to 187.4 million followed in 2020, before another drop to 161.4 million in 2021.

Market activity shifted from 2022, beginning with stabilization at 163.1 million that year before a strong 37% surge to 223.9 million in 2023. The growth was interrupted in 2024 as the market receded to 215.8 million, a movement linked to a declared supply shortage of critical depot penicillins like benzylpenicillin benzathine, essential for long-term therapies. In response, temporary special regulations were introduced, and the ALBVVG law was passed to create financial incentives for developing new antibiotics and preventing future supply gaps.

Production for retail sale medicaments with penicillins or streptomycins in Germany

In value, 2017-2020, M $ US

Germany's production of retail sale medicaments containing penicillins or streptomycins declined for the second consecutive year. In 2020, output was valued at 44.1 million US dollars, marking a 30.2% year-over-year decrease. Between 2017 and 2020, production fell by 43.6%, which translates to an annualized decline of 17.4%. The highest production value was recorded in 2018 at 109.6 million US dollars. The largest year-on-year decline occurred in 2019 with a 42.4% drop, while the largest increase was in 2018 at 40.3%.

Annual dynamics of production in Germany in value, 2017-2020, M $ US

Exports for retail sale medicaments with penicillins or streptomycins from Germany

Exports in kind, t

Exports of retail sale medicaments with penicillins or streptomycins from Germany increased for the second consecutive year. In 2020, shipments abroad reached 2 746 tonnes, up 11.8% from the previous year. Between 2017 and 2020, exports decreased by 3.8%, equating to an annualized decline of 1.3%. The lowest export volume was recorded in 2018 at 2 181 tonnes. The largest year-on-year decline occurred in 2018 with a 23.6% drop, while the largest increase was in 2019 at 12.6%.

Annual dynamics of product's exports from Germany in kind, 2017-2020, t

From 2017 to 2020, Spain, France, and the Netherlands were the primary destinations for Germany's exports of these medicaments in kind. Spain accounted for 49.3% of exports, France for 7.8%, and the Netherlands for 7.4%. Together, these three countries represented 64.4% of total export flows.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Germany in kind, 2017-2020

Exports in value, M $ US

In 2020, Germany's exports of retail sale medicaments with penicillins or streptomycins totaled 53.1 million US dollars, showing a modest decline of 4.0% compared to the previous year. The lowest export value was recorded in 2018 at 48.8 million US dollars, while the highest was in 2019 at 55.3 million US dollars. The largest year-on-year decline occurred in 2018 with an 8.4% drop, and the largest increase was in 2019 at 13.3%.

Annual dynamics of product's exports from Germany in value, 2017-2020, M $ US

Between 2017 and 2020, Germany's exports of these medicaments in value terms were distributed across numerous countries. Spain accounted for 22.1% of export value, France for 13.8%, and the Netherlands for 8.9%. Collectively, these three countries represented 44.8% of total export flows.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Germany in value, 2017-2020

Imports for retail sale medicaments with penicillins or streptomycins to Germany

Imports in kind, t

Imports of retail sale medicaments with penicillins or streptomycins into Germany increased for the third consecutive year. In 2020, import volume reached 5 765 tonnes, up 24.7% from 2019. Between 2017 and 2020, imports grew by 43.9%, which corresponds to an annualized increase of 12.9%.

Annual dynamics of product's imports to Germany in kind, 2017-2020, t

From 2017 to 2020, Austria, Portugal, and Italy were the main sources for Germany's imports of these medicaments in kind. Austria accounted for 30.4% of imports, Portugal for 24.6%, and Italy for 24.6%. Together, these three countries made up 79.6% of total import flows.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Germany in kind, 2017-2020

Imports in value, M $ US

Imports of retail sale medicaments with penicillins or streptomycins into Germany increased for the third consecutive year. In 2020, imports amounted to 196.5 million US dollars, rising 28.6% year-over-year. Over the period from 2017 to 2020, imports grew by 48.2%, with a compound annual growth rate of 14.0%.

Annual dynamics of product's imports to Germany in value, 2017-2020, M $ US

Between 2017 and 2020, Italy, Portugal, and Austria consistently led in Germany's import structure by value. Italy accounted for 23.2% of import value, Portugal for 21.6%, and Austria for 20.1%. Together, these three countries represented 64.8% of total import flows.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Germany in value, 2017-2020